Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:hypothyroidism (in 2/4 patients)'
(id=6990634 ; fe=en:hypothyroidism (in 2/4 patients) ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=9368 creation date=2017-06-25 touchdate=2025-08-28 16:42:28.000)
≈ 154 relations sortantes

  1. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 30 / 1 -> en:hypercortisolemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypercortisolemia | rel=r_associated | relid=0 | w=30
  2. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 30 / 1 -> en:hypogonadotropic hypogonadism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypogonadotropic hypogonadism | rel=r_associated | relid=0 | w=30
  3. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 30 / 1 -> infertilité de la femme
    n1=en:hypothyroidism (in 2/4 patients) | n2=infertilité de la femme | rel=r_associated | relid=0 | w=30
  4. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 29 / 0.967 -> en:congenital absence of adrenal gland
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:congenital absence of adrenal gland | rel=r_associated | relid=0 | w=29
  5. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 29 / 0.967 -> en:congenital absence of thymus
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:congenital absence of thymus | rel=r_associated | relid=0 | w=29
  6. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 29 / 0.967 -> en:hashimoto thyroiditis
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=29
  7. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 29 / 0.967 -> en:klinefelter syndrome
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:klinefelter syndrome | rel=r_associated | relid=0 | w=29
  8. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 29 / 0.967 -> hypogonadisme hypogonadotrophique
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypogonadisme hypogonadotrophique | rel=r_associated | relid=0 | w=29
  9. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 28 / 0.933 -> en:euthyroid (finding)
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:euthyroid (finding) | rel=r_associated | relid=0 | w=28
  10. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 28 / 0.933 -> en:growth hormone deficiency
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:growth hormone deficiency | rel=r_associated | relid=0 | w=28
  11. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 28 / 0.933 -> en:hypopituitarism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypopituitarism | rel=r_associated | relid=0 | w=28
  12. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 27 / 0.9 -> en:hypertension
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypertension | rel=r_associated | relid=0 | w=27
  13. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 27 / 0.9 -> en:maturity-onset diabetes of the young
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:maturity-onset diabetes of the young | rel=r_associated | relid=0 | w=27
  14. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 27 / 0.9 -> en:pituitary dwarfism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:pituitary dwarfism | rel=r_associated | relid=0 | w=27
  15. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 26 / 0.867 -> en:secondary hyperparathyroidism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:secondary hyperparathyroidism | rel=r_associated | relid=0 | w=26
  16. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 26 / 0.867 -> en:stein-leventhal syndrome
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:stein-leventhal syndrome | rel=r_associated | relid=0 | w=26
  17. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 26 / 0.867 -> en:thyroiditis
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:thyroiditis | rel=r_associated | relid=0 | w=26
  18. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 26 / 0.867 -> hyperandrogénisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=hyperandrogénisme | rel=r_associated | relid=0 | w=26
  19. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 25 / 0.833 -> en:female infertility
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:female infertility | rel=r_associated | relid=0 | w=25
  20. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 25 / 0.833 -> en:hypothyroidism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypothyroidism | rel=r_associated | relid=0 | w=25
  21. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 25 / 0.833 -> en:macronodular adrenal hyperplasia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:macronodular adrenal hyperplasia | rel=r_associated | relid=0 | w=25
  22. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 25 / 0.833 -> hyperandrogénie
    n1=en:hypothyroidism (in 2/4 patients) | n2=hyperandrogénie | rel=r_associated | relid=0 | w=25
  23. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 25 / 0.833 -> patient
    n1=en:hypothyroidism (in 2/4 patients) | n2=patient | rel=r_associated | relid=0 | w=25
  24. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 25 / 0.833 -> patients
    n1=en:hypothyroidism (in 2/4 patients) | n2=patients | rel=r_associated | relid=0 | w=25
  25. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 24 / 0.8 -> en:neonatal diabetes mellitus
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:neonatal diabetes mellitus | rel=r_associated | relid=0 | w=24
  26. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 24 / 0.8 -> en:normal pituitary function
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:normal pituitary function | rel=r_associated | relid=0 | w=24
  27. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 24 / 0.8 -> en:panhypopituitarism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:panhypopituitarism | rel=r_associated | relid=0 | w=24
  28. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 24 / 0.8 -> en:pituitary hormone deficiency
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:pituitary hormone deficiency | rel=r_associated | relid=0 | w=24
  29. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 24 / 0.8 -> infertilité féminine
    n1=en:hypothyroidism (in 2/4 patients) | n2=infertilité féminine | rel=r_associated | relid=0 | w=24
  30. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 24 / 0.8 -> stérilité féminine
    n1=en:hypothyroidism (in 2/4 patients) | n2=stérilité féminine | rel=r_associated | relid=0 | w=24
  31. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 23 / 0.767 -> en:androgen excess
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:androgen excess | rel=r_associated | relid=0 | w=23
  32. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 23 / 0.767 -> en:cushing disease
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:cushing disease | rel=r_associated | relid=0 | w=23
  33. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 23 / 0.767 -> en:hypoaldosteronemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypoaldosteronemia | rel=r_associated | relid=0 | w=23
  34. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 23 / 0.767 -> en:precocious puberty
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:precocious puberty | rel=r_associated | relid=0 | w=23
  35. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 22 / 0.733 -> en:adrenal hyperplasia, bilateral
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:adrenal hyperplasia, bilateral | rel=r_associated | relid=0 | w=22
  36. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 22 / 0.733 -> en:congenital adrenal hyperplasia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:congenital adrenal hyperplasia | rel=r_associated | relid=0 | w=22
  37. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 21 / 0.7 -> en:congenital adrenal gland hypoplasia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:congenital adrenal gland hypoplasia | rel=r_associated | relid=0 | w=21
  38. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 21 / 0.7 -> en:diabetes mellitus
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=21
  39. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 21 / 0.7 -> en:hypernatremia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypernatremia | rel=r_associated | relid=0 | w=21
  40. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> acromégalie
    n1=en:hypothyroidism (in 2/4 patients) | n2=acromégalie | rel=r_associated | relid=0 | w=20
  41. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens
    n1=en:hypothyroidism (in 2/4 patients) | n2=acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens | rel=r_associated | relid=0 | w=20
  42. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> acromegaly
    n1=en:hypothyroidism (in 2/4 patients) | n2=acromegaly | rel=r_associated | relid=0 | w=20
  43. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> déficit en hormone de croissance
    n1=en:hypothyroidism (in 2/4 patients) | n2=déficit en hormone de croissance | rel=r_associated | relid=0 | w=20
  44. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> diabète (accidents vasculaires cérébraux du)
    n1=en:hypothyroidism (in 2/4 patients) | n2=diabète (accidents vasculaires cérébraux du) | rel=r_associated | relid=0 | w=20
  45. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> diabète sucré
    n1=en:hypothyroidism (in 2/4 patients) | n2=diabète sucré | rel=r_associated | relid=0 | w=20
  46. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> diabète sucré de type 2 avec surdité
    n1=en:hypothyroidism (in 2/4 patients) | n2=diabète sucré de type 2 avec surdité | rel=r_associated | relid=0 | w=20
  47. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale
    n1=en:hypothyroidism (in 2/4 patients) | n2=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | rel=r_associated | relid=0 | w=20
  48. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:abnormal glucose tolerance test
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:abnormal glucose tolerance test | rel=r_associated | relid=0 | w=20
  49. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:acromegaly
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:acromegaly | rel=r_associated | relid=0 | w=20
  50. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:acyesis
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:acyesis | rel=r_associated | relid=0 | w=20
  51. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:addison disease
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:addison disease | rel=r_associated | relid=0 | w=20
  52. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:Addison disease
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:Addison disease | rel=r_associated | relid=0 | w=20
  53. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:addison's disease
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:addison's disease | rel=r_associated | relid=0 | w=20
  54. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:Addison's disease
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:Addison's disease | rel=r_associated | relid=0 | w=20
  55. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:adrenal cortex adenoma
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:adrenal cortex adenoma | rel=r_associated | relid=0 | w=20
  56. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:aldosterone level increased above normal
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:aldosterone level increased above normal | rel=r_associated | relid=0 | w=20
  57. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:and cerebellar ataxia due to duplication of mitochondrial DNA
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:and cerebellar ataxia due to duplication of mitochondrial DNA | rel=r_associated | relid=0 | w=20
  58. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:and hyperglycinuria
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:and hyperglycinuria | rel=r_associated | relid=0 | w=20
  59. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:arterial hypertension
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:arterial hypertension | rel=r_associated | relid=0 | w=20
  60. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:autoimmune thyroiditis
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:autoimmune thyroiditis | rel=r_associated | relid=0 | w=20
  61. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:congenital hypoplasia of thymus
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=20
  62. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:cushing syndrome
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:cushing syndrome | rel=r_associated | relid=0 | w=20
  63. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:decreased circulating renin level
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:decreased circulating renin level | rel=r_associated | relid=0 | w=20
  64. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:decreased testosterone level
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:decreased testosterone level | rel=r_associated | relid=0 | w=20
  65. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:delayed puberty
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:delayed puberty | rel=r_associated | relid=0 | w=20
  66. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:delayed puberty (in most patients)
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:delayed puberty (in most patients) | rel=r_associated | relid=0 | w=20
  67. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:ectopic thyroid gland
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:ectopic thyroid gland | rel=r_associated | relid=0 | w=20
  68. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:elevated baseline 17-hydroxypregnenolone levels
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:elevated baseline 17-hydroxypregnenolone levels | rel=r_associated | relid=0 | w=20
  69. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:elevated fasting glucose
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:elevated fasting glucose | rel=r_associated | relid=0 | w=20
  70. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:elevated fasting plasma glucose
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:elevated fasting plasma glucose | rel=r_associated | relid=0 | w=20
  71. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:elevated gonadotropin levels
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:elevated gonadotropin levels | rel=r_associated | relid=0 | w=20
  72. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:encephalopathy with intracranial calcification
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:encephalopathy with intracranial calcification | rel=r_associated | relid=0 | w=20
  73. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:fatigue
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:fatigue | rel=r_associated | relid=0 | w=20
  74. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:glucagonoma syndrome
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:glucagonoma syndrome | rel=r_associated | relid=0 | w=20
  75. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:gonadotrophin increased
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:gonadotrophin increased | rel=r_associated | relid=0 | w=20
  76. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:high blood pressure
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:high blood pressure | rel=r_associated | relid=0 | w=20
  77. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hyperaldosteronism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hyperaldosteronism | rel=r_associated | relid=0 | w=20
  78. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hyperandrogenism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hyperandrogenism | rel=r_associated | relid=0 | w=20
  79. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypercalcaemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypercalcaemia | rel=r_associated | relid=0 | w=20
  80. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypercalcemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypercalcemia | rel=r_associated | relid=0 | w=20
  81. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypernatraemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypernatraemia | rel=r_associated | relid=0 | w=20
  82. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hyperprolactinemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hyperprolactinemia | rel=r_associated | relid=0 | w=20
  83. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hyperthyroidism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hyperthyroidism | rel=r_associated | relid=0 | w=20
  84. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypoaldosteronism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypoaldosteronism | rel=r_associated | relid=0 | w=20
  85. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypocalcemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypocalcemia | rel=r_associated | relid=0 | w=20
  86. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypoglycemia, fasting
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypoglycemia, fasting | rel=r_associated | relid=0 | w=20
  87. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypogonadotrophic hypogonadism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypogonadotrophic hypogonadism | rel=r_associated | relid=0 | w=20
  88. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypothalamic hamartoblastoma
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypothalamic hamartoblastoma | rel=r_associated | relid=0 | w=20
  89. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypothyreosis
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypothyreosis | rel=r_associated | relid=0 | w=20
  90. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:hypothyroidy
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:hypothyroidy | rel=r_associated | relid=0 | w=20
  91. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:Klinefelter syndrome
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:Klinefelter syndrome | rel=r_associated | relid=0 | w=20
  92. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:low serum igf2 levels
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:low serum igf2 levels | rel=r_associated | relid=0 | w=20
  93. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:low to normal estradiol levels
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:low to normal estradiol levels | rel=r_associated | relid=0 | w=20
  94. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:nasal alar hypoplasia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:nasal alar hypoplasia | rel=r_associated | relid=0 | w=20
  95. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:neonatal hypoglycemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:neonatal hypoglycemia | rel=r_associated | relid=0 | w=20
  96. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:normal basal plasma cortisol
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:normal basal plasma cortisol | rel=r_associated | relid=0 | w=20
  97. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:normal serum igfbp3 levels
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:normal serum igfbp3 levels | rel=r_associated | relid=0 | w=20
  98. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:parathyroid gland adenoma
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=20
  99. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:premature thelarche
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:premature thelarche | rel=r_associated | relid=0 | w=20
  100. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:primary hypothyroidism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:primary hypothyroidism | rel=r_associated | relid=0 | w=20
  101. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:pseudohypoparathyroidism
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:pseudohypoparathyroidism | rel=r_associated | relid=0 | w=20
  102. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:reactive hypoglycemia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:reactive hypoglycemia | rel=r_associated | relid=0 | w=20
  103. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:renal tubulopathy
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:renal tubulopathy | rel=r_associated | relid=0 | w=20
  104. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:secondary adrenal insufficiency
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:secondary adrenal insufficiency | rel=r_associated | relid=0 | w=20
  105. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:Stein-Leventhal syndrome
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:Stein-Leventhal syndrome | rel=r_associated | relid=0 | w=20
  106. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:sugar diabetes
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:sugar diabetes | rel=r_associated | relid=0 | w=20
  107. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:syndrome of inappropriate antidiuretic hormone secretion
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:syndrome of inappropriate antidiuretic hormone secretion | rel=r_associated | relid=0 | w=20
  108. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:tachycardia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:tachycardia | rel=r_associated | relid=0 | w=20
  109. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:thyroid function normal
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:thyroid function normal | rel=r_associated | relid=0 | w=20
  110. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:thyroid gland follicular adenoma
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:thyroid gland follicular adenoma | rel=r_associated | relid=0 | w=20
  111. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:thyroid gland papillary carcinoma
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=20
  112. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> en:thyroid oncocytic metaplasia
    n1=en:hypothyroidism (in 2/4 patients) | n2=en:thyroid oncocytic metaplasia | rel=r_associated | relid=0 | w=20
  113. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne
    n1=en:hypothyroidism (in 2/4 patients) | n2=encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne | rel=r_associated | relid=0 | w=20
  114. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> glucagonome (syndrome du)
    n1=en:hypothyroidism (in 2/4 patients) | n2=glucagonome (syndrome du) | rel=r_associated | relid=0 | w=20
  115. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale
    n1=en:hypothyroidism (in 2/4 patients) | n2=hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale | rel=r_associated | relid=0 | w=20
  116. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> HTA
    n1=en:hypothyroidism (in 2/4 patients) | n2=HTA | rel=r_associated | relid=0 | w=20
  117. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hta
    n1=en:hypothyroidism (in 2/4 patients) | n2=hta | rel=r_associated | relid=0 | w=20
  118. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> HTA
    (hypertension artérielle)
    n1=en:hypothyroidism (in 2/4 patients) | n2=HTA
    (hypertension artérielle)
    | rel=r_associated | relid=0 | w=20
  119. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hyperaldostéronisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=hyperaldostéronisme | rel=r_associated | relid=0 | w=20
  120. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypercalcémie
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypercalcémie | rel=r_associated | relid=0 | w=20
  121. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hyperplasie congénitale des surrénales
    n1=en:hypothyroidism (in 2/4 patients) | n2=hyperplasie congénitale des surrénales | rel=r_associated | relid=0 | w=20
  122. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypertélorisme, hypospadias, polysyndactylie (syndrome)
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypertélorisme, hypospadias, polysyndactylie (syndrome) | rel=r_associated | relid=0 | w=20
  123. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypertension
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypertension | rel=r_associated | relid=0 | w=20
  124. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypertension artérielle
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypertension artérielle | rel=r_associated | relid=0 | w=20
  125. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hyperthyroïdie
    n1=en:hypothyroidism (in 2/4 patients) | n2=hyperthyroïdie | rel=r_associated | relid=0 | w=20
  126. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hyperthyroïdisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=hyperthyroïdisme | rel=r_associated | relid=0 | w=20
  127. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypo-aldostéronisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypo-aldostéronisme | rel=r_associated | relid=0 | w=20
  128. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypoactivité de l'hypophyse
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypoactivité de l'hypophyse | rel=r_associated | relid=0 | w=20
  129. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypoaldostéronisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypoaldostéronisme | rel=r_associated | relid=0 | w=20
  130. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypocalcémie
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypocalcémie | rel=r_associated | relid=0 | w=20
  131. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypoglycémie du nouveau-né
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypoglycémie du nouveau-né | rel=r_associated | relid=0 | w=20
  132. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypohypophysie
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypohypophysie | rel=r_associated | relid=0 | w=20
  133. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypopituitarisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypopituitarisme | rel=r_associated | relid=0 | w=20
  134. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale | rel=r_associated | relid=0 | w=20
  135. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypostimulinie
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypostimulinie | rel=r_associated | relid=0 | w=20
  136. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypothyroïdie
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypothyroïdie | rel=r_associated | relid=0 | w=20
  137. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> hypothyroïdisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=hypothyroïdisme | rel=r_associated | relid=0 | w=20
  138. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> insuffisance surrénalienne chronique primaire
    n1=en:hypothyroidism (in 2/4 patients) | n2=insuffisance surrénalienne chronique primaire | rel=r_associated | relid=0 | w=20
  139. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> maladie d'Addison
    n1=en:hypothyroidism (in 2/4 patients) | n2=maladie d'Addison | rel=r_associated | relid=0 | w=20
  140. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> maladie d'addison
    n1=en:hypothyroidism (in 2/4 patients) | n2=maladie d'addison | rel=r_associated | relid=0 | w=20
  141. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> panhypopituitarisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=panhypopituitarisme | rel=r_associated | relid=0 | w=20
  142. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> pseudo-hypoparathyroïdie
    n1=en:hypothyroidism (in 2/4 patients) | n2=pseudo-hypoparathyroïdie | rel=r_associated | relid=0 | w=20
  143. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> pseudo-hypoparathyroïdisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=pseudo-hypoparathyroïdisme | rel=r_associated | relid=0 | w=20
  144. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> pseudohypoparathyroïdie
    n1=en:hypothyroidism (in 2/4 patients) | n2=pseudohypoparathyroïdie | rel=r_associated | relid=0 | w=20
  145. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> pseudohypoparathyroïdisme
    n1=en:hypothyroidism (in 2/4 patients) | n2=pseudohypoparathyroïdisme | rel=r_associated | relid=0 | w=20
  146. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> puberté précoce
    n1=en:hypothyroidism (in 2/4 patients) | n2=puberté précoce | rel=r_associated | relid=0 | w=20
  147. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> Puberté précoce
    n1=en:hypothyroidism (in 2/4 patients) | n2=Puberté précoce | rel=r_associated | relid=0 | w=20
  148. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> puberté retardée
    n1=en:hypothyroidism (in 2/4 patients) | n2=puberté retardée | rel=r_associated | relid=0 | w=20
  149. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> puberté rétardée
    n1=en:hypothyroidism (in 2/4 patients) | n2=puberté rétardée | rel=r_associated | relid=0 | w=20
  150. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> puberté tardive
    n1=en:hypothyroidism (in 2/4 patients) | n2=puberté tardive | rel=r_associated | relid=0 | w=20
  151. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> retard pubertaire
    n1=en:hypothyroidism (in 2/4 patients) | n2=retard pubertaire | rel=r_associated | relid=0 | w=20
  152. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> tachycardie, hypertension, microphtalmie et hyperglycinurie
    n1=en:hypothyroidism (in 2/4 patients) | n2=tachycardie, hypertension, microphtalmie et hyperglycinurie | rel=r_associated | relid=0 | w=20
  153. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> thyroïdite
    n1=en:hypothyroidism (in 2/4 patients) | n2=thyroïdite | rel=r_associated | relid=0 | w=20
  154. en:hypothyroidism (in 2/4 patients) -- r_associated #0: 20 / 0.667 -> tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial
    n1=en:hypothyroidism (in 2/4 patients) | n2=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | rel=r_associated | relid=0 | w=20
≈ 247 relations entrantes

  1. infertilité de la femme --- r_associated #0: 260 --> en:hypothyroidism (in 2/4 patients)
    n1=infertilité de la femme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=260
  2. en:female infertility --- r_associated #0: 258 --> en:hypothyroidism (in 2/4 patients)
    n1=en:female infertility | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=258
  3. hyperandrogénisme --- r_associated #0: 181 --> en:hypothyroidism (in 2/4 patients)
    n1=hyperandrogénisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=181
  4. en:androgen excess --- r_associated #0: 180 --> en:hypothyroidism (in 2/4 patients)
    n1=en:androgen excess | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=180
  5. en:hyperandrogenism --- r_associated #0: 180 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hyperandrogenism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=180
  6. hyperandrogénie --- r_associated #0: 175 --> en:hypothyroidism (in 2/4 patients)
    n1=hyperandrogénie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=175
  7. infertilité féminine --- r_associated #0: 166 --> en:hypothyroidism (in 2/4 patients)
    n1=infertilité féminine | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=166
  8. stérilité féminine --- r_associated #0: 161 --> en:hypothyroidism (in 2/4 patients)
    n1=stérilité féminine | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=161
  9. hypo-aldostéronisme --- r_associated #0: 149 --> en:hypothyroidism (in 2/4 patients)
    n1=hypo-aldostéronisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=149
  10. en:hypoaldosteronemia --- r_associated #0: 146 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypoaldosteronemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=146
  11. hypoaldostéronisme --- r_associated #0: 145 --> en:hypothyroidism (in 2/4 patients)
    n1=hypoaldostéronisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=145
  12. en:hypoaldosteronism --- r_associated #0: 140 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypoaldosteronism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=140
  13. en:hypertension --- r_associated #0: 106 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypertension | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=106
  14. hypertension --- r_associated #0: 105 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertension | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=105
  15. puberté retardée --- r_associated #0: 100 --> en:hypothyroidism (in 2/4 patients)
    n1=puberté retardée | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=100
  16. puberté rétardée --- r_associated #0: 100 --> en:hypothyroidism (in 2/4 patients)
    n1=puberté rétardée | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=100
  17. en:delayed puberty --- r_associated #0: 99 --> en:hypothyroidism (in 2/4 patients)
    n1=en:delayed puberty | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=99
  18. hyperplasie congénitale des surrénales --- r_associated #0: 95 --> en:hypothyroidism (in 2/4 patients)
    n1=hyperplasie congénitale des surrénales | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=95
  19. en:congenital adrenal hyperplasia --- r_associated #0: 92 --> en:hypothyroidism (in 2/4 patients)
    n1=en:congenital adrenal hyperplasia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=92
  20. puberté tardive --- r_associated #0: 91 --> en:hypothyroidism (in 2/4 patients)
    n1=puberté tardive | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=91
  21. en:high blood pressure --- r_associated #0: 90 --> en:hypothyroidism (in 2/4 patients)
    n1=en:high blood pressure | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=90
  22. hypopituitarisme --- r_associated #0: 85 --> en:hypothyroidism (in 2/4 patients)
    n1=hypopituitarisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=85
  23. en:hypopituitarism --- r_associated #0: 84 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypopituitarism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=84
  24. hypothyroïdisme --- r_associated #0: 83 --> en:hypothyroidism (in 2/4 patients)
    n1=hypothyroïdisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=83
  25. en:hypothyroidism --- r_associated #0: 80 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypothyroidism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=80
  26. hypertension artérielle --- r_associated #0: 80 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertension artérielle | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=80
  27. diabète sucré --- r_associated #0: 75 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète sucré | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=75
  28. en:sugar diabetes --- r_associated #0: 75 --> en:hypothyroidism (in 2/4 patients)
    n1=en:sugar diabetes | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=75
  29. hyperaldostéronisme --- r_associated #0: 74 --> en:hypothyroidism (in 2/4 patients)
    n1=hyperaldostéronisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=74
  30. panhypopituitarisme --- r_associated #0: 73 --> en:hypothyroidism (in 2/4 patients)
    n1=panhypopituitarisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=73
  31. en:diabetes mellitus --- r_associated #0: 72 --> en:hypothyroidism (in 2/4 patients)
    n1=en:diabetes mellitus | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=72
  32. en:hyperaldosteronism --- r_associated #0: 72 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hyperaldosteronism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=72
  33. en:panhypopituitarism --- r_associated #0: 71 --> en:hypothyroidism (in 2/4 patients)
    n1=en:panhypopituitarism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=71
  34. HTA
    (hypertension artérielle)
     --- r_associated #0: 65 --> en:hypothyroidism (in 2/4 patients)
    n1=HTA
    (hypertension artérielle)
    | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=65
  35. hypothyroïdie --- r_associated #0: 63 --> en:hypothyroidism (in 2/4 patients)
    n1=hypothyroïdie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=63
  36. maladie d'addison --- r_associated #0: 63 --> en:hypothyroidism (in 2/4 patients)
    n1=maladie d'addison | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=63
  37. hyperthyroïdisme --- r_associated #0: 62 --> en:hypothyroidism (in 2/4 patients)
    n1=hyperthyroïdisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=62
  38. pseudo-hypoparathyroïdie --- r_associated #0: 62 --> en:hypothyroidism (in 2/4 patients)
    n1=pseudo-hypoparathyroïdie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=62
  39. hyperthyroïdie --- r_associated #0: 61 --> en:hypothyroidism (in 2/4 patients)
    n1=hyperthyroïdie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=61
  40. en:Klinefelter syndrome --- r_associated #0: 60 --> en:hypothyroidism (in 2/4 patients)
    n1=en:Klinefelter syndrome | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=60
  41. en:hyperthyroidism --- r_associated #0: 60 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hyperthyroidism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=60
  42. pseudo-hypoparathyroïdisme --- r_associated #0: 60 --> en:hypothyroidism (in 2/4 patients)
    n1=pseudo-hypoparathyroïdisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=60
  43. pseudohypoparathyroïdie --- r_associated #0: 60 --> en:hypothyroidism (in 2/4 patients)
    n1=pseudohypoparathyroïdie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=60
  44. en:addison disease --- r_associated #0: 59 --> en:hypothyroidism (in 2/4 patients)
    n1=en:addison disease | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=59
  45. pseudohypoparathyroïdisme --- r_associated #0: 58 --> en:hypothyroidism (in 2/4 patients)
    n1=pseudohypoparathyroïdisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=58
  46. en:klinefelter syndrome --- r_associated #0: 56 --> en:hypothyroidism (in 2/4 patients)
    n1=en:klinefelter syndrome | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=56
  47. en:pseudohypoparathyroidism --- r_associated #0: 55 --> en:hypothyroidism (in 2/4 patients)
    n1=en:pseudohypoparathyroidism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=55
  48. maladie d'Addison --- r_associated #0: 54 --> en:hypothyroidism (in 2/4 patients)
    n1=maladie d'Addison | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=54
  49. insuffisance surrénalienne chronique primaire --- r_associated #0: 52 --> en:hypothyroidism (in 2/4 patients)
    n1=insuffisance surrénalienne chronique primaire | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=52
  50. hta --- r_associated #0: 50 --> en:hypothyroidism (in 2/4 patients)
    n1=hta | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=50
  51. tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial --- r_associated #0: 47 --> en:hypothyroidism (in 2/4 patients)
    n1=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=47
  52. en:Addison's disease --- r_associated #0: 46 --> en:hypothyroidism (in 2/4 patients)
    n1=en:Addison's disease | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=46
  53. en:addison's disease --- r_associated #0: 46 --> en:hypothyroidism (in 2/4 patients)
    n1=en:addison's disease | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=46
  54. Puberté précoce --- r_associated #0: 44 --> en:hypothyroidism (in 2/4 patients)
    n1=Puberté précoce | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=44
  55. diabète sucré de type 2 avec surdité --- r_associated #0: 42 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète sucré de type 2 avec surdité | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=42
  56. tachycardie, hypertension, microphtalmie et hyperglycinurie --- r_associated #0: 42 --> en:hypothyroidism (in 2/4 patients)
    n1=tachycardie, hypertension, microphtalmie et hyperglycinurie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=42
  57. retard pubertaire --- r_associated #0: 41 --> en:hypothyroidism (in 2/4 patients)
    n1=retard pubertaire | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=41
  58. en:adrenal hyperplasia, bilateral --- r_associated #0: 40 --> en:hypothyroidism (in 2/4 patients)
    n1=en:adrenal hyperplasia, bilateral | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=40
  59. en:hypothyroidy --- r_associated #0: 40 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypothyroidy | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=40
  60. en:precocious puberty --- r_associated #0: 40 --> en:hypothyroidism (in 2/4 patients)
    n1=en:precocious puberty | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=40
  61. puberté précoce --- r_associated #0: 40 --> en:hypothyroidism (in 2/4 patients)
    n1=puberté précoce | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=40
  62. diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale --- r_associated #0: 38 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=38
  63. en:hashimoto thyroiditis --- r_associated #0: 38 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hashimoto thyroiditis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=38
  64. hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale --- r_associated #0: 38 --> en:hypothyroidism (in 2/4 patients)
    n1=hamartoblastome hypothalamique, hypopituitarisme, imperforation anale et polydactylie post-axiale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=38
  65. en:macronodular adrenal hyperplasia --- r_associated #0: 37 --> en:hypothyroidism (in 2/4 patients)
    n1=en:macronodular adrenal hyperplasia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=37
  66. en:arterial hypertension --- r_associated #0: 36 --> en:hypothyroidism (in 2/4 patients)
    n1=en:arterial hypertension | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=36
  67. diabète (accidents vasculaires cérébraux du) --- r_associated #0: 35 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète (accidents vasculaires cérébraux du) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=35
  68. en:congenital adrenal gland hypoplasia --- r_associated #0: 35 --> en:hypothyroidism (in 2/4 patients)
    n1=en:congenital adrenal gland hypoplasia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=35
  69. en:decreased testosterone level --- r_associated #0: 35 --> en:hypothyroidism (in 2/4 patients)
    n1=en:decreased testosterone level | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=35
  70. en:elevated fasting plasma glucose --- r_associated #0: 35 --> en:hypothyroidism (in 2/4 patients)
    n1=en:elevated fasting plasma glucose | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=35
  71. en:hypernatremia --- r_associated #0: 35 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypernatremia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=35
  72. en:delayed puberty (in most patients) --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:delayed puberty (in most patients) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  73. en:elevated baseline 17-hydroxypregnenolone levels --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:elevated baseline 17-hydroxypregnenolone levels | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  74. en:euthyroid (finding) --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:euthyroid (finding) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  75. en:hypercalcemia --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypercalcemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  76. en:low to normal estradiol levels --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:low to normal estradiol levels | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  77. en:normal basal plasma cortisol --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:normal basal plasma cortisol | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  78. en:premature thelarche --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:premature thelarche | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  79. en:secondary hyperparathyroidism --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:secondary hyperparathyroidism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  80. en:syndrome of inappropriate antidiuretic hormone secretion --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=en:syndrome of inappropriate antidiuretic hormone secretion | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  81. glucagonome (syndrome du) --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=glucagonome (syndrome du) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  82. hypercalcémie --- r_associated #0: 34 --> en:hypothyroidism (in 2/4 patients)
    n1=hypercalcémie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=34
  83. en:glucagonoma syndrome --- r_associated #0: 33 --> en:hypothyroidism (in 2/4 patients)
    n1=en:glucagonoma syndrome | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=33
  84. hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale --- r_associated #0: 33 --> en:hypothyroidism (in 2/4 patients)
    n1=hypoplasie des ailes du nez-hypothyroïdisme-absence de sécrétion pancréatique-surdité congénitale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=33
  85. hypostimulinie --- r_associated #0: 33 --> en:hypothyroidism (in 2/4 patients)
    n1=hypostimulinie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=33
  86. en:congenital hypoplasia of thymus --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:congenital hypoplasia of thymus | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  87. en:ectopic thyroid gland --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:ectopic thyroid gland | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  88. en:hypocalcemia --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypocalcemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  89. en:low serum igf2 levels --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:low serum igf2 levels | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  90. en:pituitary dwarfism --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:pituitary dwarfism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  91. en:reactive hypoglycemia --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:reactive hypoglycemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  92. en:renal tubulopathy --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:renal tubulopathy | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  93. en:secondary adrenal insufficiency --- r_associated #0: 32 --> en:hypothyroidism (in 2/4 patients)
    n1=en:secondary adrenal insufficiency | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=32
  94. déficit en hormone de croissance --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=déficit en hormone de croissance | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  95. en:congenital absence of adrenal gland --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=en:congenital absence of adrenal gland | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  96. en:growth hormone deficiency --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=en:growth hormone deficiency | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  97. en:hypothyreosis --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypothyreosis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  98. en:normal pituitary function --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=en:normal pituitary function | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  99. en:normal serum igfbp3 levels --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=en:normal serum igfbp3 levels | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  100. en:overactive thyroid --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=en:overactive thyroid | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  101. en:tachycardia --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=en:tachycardia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  102. encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=encéphalopathie avec calcification intracrânienne, déficience en hormone de croissance, microcéphalie et dégénérescence rétinienne | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  103. hypoglycémie du nouveau-né --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=hypoglycémie du nouveau-né | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  104. hypohypophysie --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=hypohypophysie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  105. retard de la puberté --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=retard de la puberté | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  106. thyroidite --- r_associated #0: 31 --> en:hypothyroidism (in 2/4 patients)
    n1=thyroidite | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=31
  107. Hypertension artérielle --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=Hypertension artérielle | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  108. en:Addison disease --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:Addison disease | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  109. en:acyesis --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:acyesis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  110. en:and hyperglycinuria --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:and hyperglycinuria | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  111. en:autoimmune thyroiditis --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:autoimmune thyroiditis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  112. en:congenital absence of thymus --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:congenital absence of thymus | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  113. en:elevated fasting glucose --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:elevated fasting glucose | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  114. en:elevated gonadotropin levels --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:elevated gonadotropin levels | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  115. en:encephalopathy with intracranial calcification --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:encephalopathy with intracranial calcification | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  116. en:hypercortisolemia --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypercortisolemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  117. en:hyperprolactinemia --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hyperprolactinemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  118. en:hypoglycemia, fasting --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypoglycemia, fasting | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  119. en:hypogonadotrophic hypogonadism --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypogonadotrophic hypogonadism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  120. en:hypogonadotropic hypogonadism --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypogonadotropic hypogonadism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  121. en:thyroid oncocytic metaplasia --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:thyroid oncocytic metaplasia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  122. en:thyroiditis --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=en:thyroiditis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  123. hypertélorisme, hypospadias, polysyndactylie (syndrome) --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertélorisme, hypospadias, polysyndactylie (syndrome) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  124. hypoactivité de l'hypophyse --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=hypoactivité de l'hypophyse | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  125. hypogonadisme hypogonadotrophique --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=hypogonadisme hypogonadotrophique | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  126. thyroïdite --- r_associated #0: 30 --> en:hypothyroidism (in 2/4 patients)
    n1=thyroïdite | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=30
  127. acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=acromégalie, plis cutanés de la face et du cuir chevelu, et leucomes cornéens | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  128. en:abnormal glucose tolerance test --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:abnormal glucose tolerance test | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  129. en:adrenal cortex adenoma --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:adrenal cortex adenoma | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  130. en:aldosterone level increased above normal --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:aldosterone level increased above normal | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  131. en:hypercalcaemia --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypercalcaemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  132. en:hypernatraemia --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypernatraemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  133. en:nasal alar hypoplasia --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:nasal alar hypoplasia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  134. en:parathyroid gland adenoma --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:parathyroid gland adenoma | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  135. en:primary hypothyroidism --- r_associated #0: 29 --> en:hypothyroidism (in 2/4 patients)
    n1=en:primary hypothyroidism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=29
  136. HTA --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=HTA | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  137. en:Stein-Leventhal syndrome --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:Stein-Leventhal syndrome | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  138. en:and cerebellar ataxia due to duplication of mitochondrial DNA --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:and cerebellar ataxia due to duplication of mitochondrial DNA | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  139. en:cushing disease --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:cushing disease | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  140. en:cushing syndrome --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:cushing syndrome | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  141. en:fatigue --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:fatigue | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  142. en:neonatal hypoglycemia --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:neonatal hypoglycemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  143. en:pituitary hormone deficiency --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:pituitary hormone deficiency | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  144. en:thyroid function normal --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:thyroid function normal | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  145. en:thyroid gland follicular adenoma --- r_associated #0: 28 --> en:hypothyroidism (in 2/4 patients)
    n1=en:thyroid gland follicular adenoma | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=28
  146. acromegaly --- r_associated #0: 27 --> en:hypothyroidism (in 2/4 patients)
    n1=acromegaly | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=27
  147. acromégalie --- r_associated #0: 27 --> en:hypothyroidism (in 2/4 patients)
    n1=acromégalie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=27
  148. en:acromegaly --- r_associated #0: 27 --> en:hypothyroidism (in 2/4 patients)
    n1=en:acromegaly | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=27
  149. en:hypothalamic hamartoblastoma --- r_associated #0: 27 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypothalamic hamartoblastoma | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=27
  150. en:neonatal diabetes mellitus --- r_associated #0: 27 --> en:hypothyroidism (in 2/4 patients)
    n1=en:neonatal diabetes mellitus | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=27
  151. en:stein-leventhal syndrome --- r_associated #0: 27 --> en:hypothyroidism (in 2/4 patients)
    n1=en:stein-leventhal syndrome | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=27
  152. en:thyroid gland papillary carcinoma --- r_associated #0: 27 --> en:hypothyroidism (in 2/4 patients)
    n1=en:thyroid gland papillary carcinoma | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=27
  153. en:decreased circulating renin level --- r_associated #0: 26 --> en:hypothyroidism (in 2/4 patients)
    n1=en:decreased circulating renin level | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=26
  154. en:gonadotrophin increased --- r_associated #0: 26 --> en:hypothyroidism (in 2/4 patients)
    n1=en:gonadotrophin increased | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=26
  155. en:maturity-onset diabetes of the young --- r_associated #0: 26 --> en:hypothyroidism (in 2/4 patients)
    n1=en:maturity-onset diabetes of the young | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=26
  156. hypocalcémie --- r_associated #0: 26 --> en:hypothyroidism (in 2/4 patients)
    n1=hypocalcémie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=26
  157. thyréoïdite --- r_associated #0: 26 --> en:hypothyroidism (in 2/4 patients)
    n1=thyréoïdite | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=26
  158. en:infertilitas feminis --- r_associated #0: 25 --> en:hypothyroidism (in 2/4 patients)
    n1=en:infertilitas feminis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=25
  159. tachycardie --- r_associated #0: 25 --> en:hypothyroidism (in 2/4 patients)
    n1=tachycardie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=25
  160. en:photomyoclonus --- r_associated #0: 23 --> en:hypothyroidism (in 2/4 patients)
    n1=en:photomyoclonus | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=23
  161. en:uroglycosis --- r_associated #0: 23 --> en:hypothyroidism (in 2/4 patients)
    n1=en:uroglycosis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=23
  162. en:hyperandrogeny --- r_associated #0: 22 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hyperandrogeny | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=22
  163. en:urophtisis --- r_associated #0: 22 --> en:hypothyroidism (in 2/4 patients)
    n1=en:urophtisis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=22
  164. déficit enzymatique partiel de la surrénale --- r_associated #0: 21 --> en:hypothyroidism (in 2/4 patients)
    n1=déficit enzymatique partiel de la surrénale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=21
  165. en:microphtalmia --- r_associated #0: 21 --> en:hypothyroidism (in 2/4 patients)
    n1=en:microphtalmia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=21
  166. hypernatrémie --- r_associated #0: 21 --> en:hypothyroidism (in 2/4 patients)
    n1=hypernatrémie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=21
  167. Tachycardie --- r_associated #0: 20 --> en:hypothyroidism (in 2/4 patients)
    n1=Tachycardie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=20
  168. Diabète sucré --- r_associated #0: 15 --> en:hypothyroidism (in 2/4 patients)
    n1=Diabète sucré | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=15
  169. HyperTension --- r_associated #0: 15 --> en:hypothyroidism (in 2/4 patients)
    n1=HyperTension | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=15
  170. Hyperplasie congénitale des surrénales --- r_associated #0: 15 --> en:hypothyroidism (in 2/4 patients)
    n1=Hyperplasie congénitale des surrénales | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=15
  171. Infertilité féminine --- r_associated #0: 15 --> en:hypothyroidism (in 2/4 patients)
    n1=Infertilité féminine | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=15
  172. en:hypocalcaemia --- r_associated #0: 15 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypocalcaemia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=15
  173. hyodésoxycholique (acide) --- r_associated #0: 15 --> en:hypothyroidism (in 2/4 patients)
    n1=hyodésoxycholique (acide) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=15
  174. hypermobilité articulaire (syndrome d') --- r_associated #0: 15 --> en:hypothyroidism (in 2/4 patients)
    n1=hypermobilité articulaire (syndrome d') | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=15
  175. Acromégalie --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Acromégalie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  176. Déficit en hormone de croissance --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Déficit en hormone de croissance | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  177. Haltia-Santavuori (maladie de) --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Haltia-Santavuori (maladie de) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  178. Hta --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hta | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  179. Hyperaldostéronisme --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hyperaldostéronisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  180. Hypercalcémie --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hypercalcémie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  181. Hypernatrémie --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hypernatrémie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  182. Hypertension --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hypertension | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  183. Hyperthyroïdie --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hyperthyroïdie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  184. Hypocalcémie --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hypocalcémie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  185. Hypopituitarisme --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hypopituitarisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  186. Hypothyroïdie --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Hypothyroïdie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  187. Puberté tardive --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Puberté tardive | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  188. Thyroïdite --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=Thyroïdite | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  189. battement rapide du coeur --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=battement rapide du coeur | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  190. diabète non-insulinodépendant --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète non-insulinodépendant | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  191. diabète phosphaté --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète phosphaté | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  192. diabète post-transplantation --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète post-transplantation | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  193. diabète rénal --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète rénal | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  194. en:acromegalia --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:acromegalia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  195. en:and cerebral dysfonction --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:and cerebral dysfonction | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  196. en:and congenital deafness --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:and congenital deafness | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  197. en:and postaxil polydactylie --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:and postaxil polydactylie | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  198. en:and retinal degeneration --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:and retinal degeneration | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  199. en:deafness --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:deafness | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  200. en:diabetic strokes --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:diabetic strokes | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  201. en:hyodeoxycholic acid --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hyodeoxycholic acid | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  202. en:hypertelorism --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypertelorism | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  203. en:hypospadias --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:hypospadias | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  204. en:imperforate anus --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:imperforate anus | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  205. en:microcephaly --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:microcephaly | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  206. en:necrolytic migratory erythema --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:necrolytic migratory erythema | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  207. en:nephropathy --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:nephropathy | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  208. en:pancreatic achylia --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:pancreatic achylia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  209. en:polysyndactyly syndrome --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:polysyndactyly syndrome | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  210. en:synchopexia --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:synchopexia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  211. en:tachyrhythmia --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:tachyrhythmia | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  212. en:tachysystole --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:tachysystole | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  213. en:thyroadenitis --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:thyroadenitis | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  214. en:type II --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:type II | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  215. en:with deafness --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=en:with deafness | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  216. fréquence cardiaque élevée --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=fréquence cardiaque élevée | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  217. glucane --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=glucane | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  218. glucidase --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=glucidase | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  219. glucide --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=glucide | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  220. hypertensinase --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertensinase | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  221. hypertensine --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertensine | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  222. hypertensinogène --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertensinogène | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  223. hypertension abdominale --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertension abdominale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  224. hypertélorisme-microtie-fente faciale --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=hypertélorisme-microtie-fente faciale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  225. hypothyroïdie et psychisme --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=hypothyroïdie et psychisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  226. syndrome de Stein-Leventhal-Cohen --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=syndrome de Stein-Leventhal-Cohen | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  227. thyroïdien (cancer) --- r_associated #0: 10 --> en:hypothyroidism (in 2/4 patients)
    n1=thyroïdien (cancer) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=10
  228. Addison (maladie d') --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=Addison (maladie d') | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  229. Maladie d'Addison --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=Maladie d'Addison | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  230. diabète bronzé --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète bronzé | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  231. diabète de type 1 --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète de type 1 | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  232. diabète de type 2 --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète de type 2 | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  233. diabète et psychisme --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète et psychisme | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  234. diabète et surdité d'origine mitochondriale --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète et surdité d'origine mitochondriale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  235. diabète gestationnel --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète gestationnel | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  236. diabète gras --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète gras | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  237. diabète insipide --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète insipide | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  238. diabète insipide néphrogénique --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète insipide néphrogénique | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  239. diabète insulino-requérant --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète insulino-requérant | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  240. diabète insulinodépendant --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète insulinodépendant | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  241. diabète lipoatrophique congénital --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète lipoatrophique congénital | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  242. diabète sucré et complications rénales --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabète sucré et complications rénales | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  243. diabètes monogéniques --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabètes monogéniques | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  244. diabètes sucrés et insipides avec atrophie optique et surdité --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabètes sucrés et insipides avec atrophie optique et surdité | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  245. diabétide génitale --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=diabétide génitale | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  246. syndrome d'hypermobilité articulaire --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=syndrome d'hypermobilité articulaire | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
  247. taches blanches évanescentes (syndrome des) --- r_associated #0: 5 --> en:hypothyroidism (in 2/4 patients)
    n1=taches blanches évanescentes (syndrome des) | n2=en:hypothyroidism (in 2/4 patients) | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr